Navigation Links
Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance

RALEIGH, N.C., Aug. 7 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Darius Naigamwalla has been appointed Senior Vice President and head of the firm's Brand Management Practice. Mr. Naigamwalla replaces Nader Naeymi-Rad, who was recently promoted to Chief Operating Officer at the firm.

Mr. Naigamwalla has been a member of the Brand Management Practice since joining the firm in 2001. Since that time, he has worked across all service areas of the Brand Management Practice, from new product planning and market forecasting to commercial strategy development and launch excellence. Mr. Naigamwalla has helped dozens of companies in the United States, Canada, the United Kingdom, and Europe develop comprehensive commercial launch strategies across a range of therapeutic areas including cardiology, pulmonology, rheumatology, orthopedics, virology, hematology, hepatology, gastroenterology, critical care, nephrology, oncology, and endocrinology.

In his new role as the head of the Brand Management Practice, Mr. Naigamwalla will oversee the practice's complete operations in North America, the United Kingdom, and Europe.

"Darius is one of the most focused and disciplined individuals I've worked with over the span of my career in the pharmaceutical and biotech industry. Since his first year at Campbell Alliance, Darius has always been one of our most commonly requested consultants. He has developed and maintained an exceptional track record of client satisfaction-one of the founding principles and key success factors for the growth of Campbell Alliance overall. Regardless of the task at hand, Darius has consistently overcome significant obstacles to help meet the needs of our clients," stated John Campbell, CEO of Campbell Alliance.

Mr. Naigamwalla holds an MBA from the University of Victoria, an MS in biochemistry and molecular biology from the University of Western Ontario, and a BS (with honors) in biochemistry from McMaster University.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit .


James Forte

Director, Public and Media Relations

Campbell Alliance

+1 919 844 7100, extension 7195

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
2. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
3. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
4. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
5. James T. Glover Appointed to Board of Directors of Varian, Inc.
6. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
7. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
8. Danong Chen appointed CEO of Theranostics Health
9. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
10. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
11. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
(Date:11/24/2015)... ... 24, 2015 , ... This fall, global software solutions leader SAP and AdVenture ... develop and pitch their BIG ideas to improve health and wellness in their schools. ... to win the title of SAP's Teen Innovator, an all-expenses paid trip to Super ...
(Date:11/24/2015)... November 24, 2015 --> ... research report released by Transparency Market Research, the global ... a CAGR of 17.5% during the period between 2014 ... - Global Industry Analysis, Size, Volume, Share, Growth, Trends ... prenatal testing market to reach a valuation of US$2.38 ...
(Date:11/24/2015)... 2015  Twist Bioscience, a company focused on ... Twist Bioscience chief executive officer, will present at ... 1, 2015 at 3:10 p.m. Eastern Time at The Lotte ... --> --> About ... is on Twitter. Sign up to follow our ...
Breaking Biology Technology:
(Date:11/9/2015)... ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a ... that it has released a new version of its ... in North America have already ... v4.0 also includes a FIDO UAF certified server ... already preparing to activate FIDO features. These customers include ...
Breaking Biology News(10 mins):